Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Jul 15, 2020; 12(7): 741-755
Published online Jul 15, 2020. doi: 10.4251/wjgo.v12.i7.741
Published online Jul 15, 2020. doi: 10.4251/wjgo.v12.i7.741
Figure 7 In patients with gastric cancer, wild-type TP53 cases (W) have a longer survival time, compared with mutant TP53 carcinomas, especially in tumors diagnosed before the occurrence of lymph node metastases.
- Citation: Gurzu S, Jung I, Sugimura H, Stefan-van Staden RI, Yamada H, Natsume H, Iwashita Y, Szodorai R, Szederjesi J. Maspin subcellular expression in wild-type and mutant TP53 gastric cancers. World J Gastrointest Oncol 2020; 12(7): 741-755
- URL: https://www.wjgnet.com/1948-5204/full/v12/i7/741.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i7.741